How Does Marvelon Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Marvelon Works

  • Active ingredients: Desogestrel (150 µg, a progestogen) and ethinyl estradiol (30 µg, an oestrogen).
  • Primary actions: Prevents ovulation, thickens cervical mucus, and alters the endometrium to inhibit implantation.
  • Onset & duration: Immediate protection if started correctly; maintains efficacy through 21‑day active pills and 7‑day break.
  • Metabolism: Desogestrel is a prodrug activated in the liver to etonogestrel; both components are metabolised by CYP enzymes and excreted renally and faecally.
  • Reversibility: Fertility returns rapidly after discontinuation; no long‑term impact on future pregnancy chances.

Marvelon is a combined oral contraceptive pill that uses two hormones to prevent pregnancy. This guide explains the scientific mechanisms behind its effectiveness, from molecular interactions to systemic metabolism.

Important Medical Advice

Combined hormonal contraceptives like Marvelon slightly increase the risk of blood clots (venous thromboembolism). Seek urgent medical attention if you experience sudden leg swelling/pain, unexplained breathlessness, chest pain, or sudden severe headache. See section 2 of the PIL for full symptom list.

Chemical Composition & Molecular Structure

Marvelon contains two active pharmaceutical ingredients: desogestrel (a third‑generation progestogen) and ethinyl estradiol (a synthetic oestrogen). Each white tablet delivers 150 micrograms of desogestrel and 30 micrograms of ethinyl estradiol, with lactose monohydrate as the main excipient.

Structural Details

Desogestrel

13‑ethyl‑11‑methylene‑18,19‑dinor‑17α‑pregn‑4‑en‑20‑yn‑17‑ol

A prodrug that is rapidly converted in the liver to its active metabolite, etonogestrel (3‑keto‑desogestrel). It has high selectivity for progesterone receptors, with minimal androgenic activity.

Ethinyl estradiol

19‑nor‑17α‑pregna‑1,3,5(10)‑trien‑20‑yne‑3,17‑diol

A synthetic derivative of estradiol with an ethinyl group at C17, which slows hepatic metabolism and allows oral bioavailability. It binds to oestrogen receptors throughout the body.

Key Pharmaceutical Properties

PropertyDesogestrel (active metabolite etonogestrel)Ethinyl estradiol
Lipophilicity (logP)~3.9 (etonogestrel)~3.7
Protein binding98% (albumin, SHBG)98% (albumin)
Oral bioavailabilityDesogestrel ~76% (extensive first‑pass activation)~45% (first‑pass metabolism)
Receptor affinityHigh progesterone receptor agonistOestrogen receptor agonist

🗒️ Pharmaceutical insight: The ethinyl group in ethinyl estradiol protects the molecule from rapid oxidation, extending its half‑life and allowing once‑daily dosing.

Mechanism of Action: Dual Hormonal Pathway

Marvelon exerts its contraceptive effect through three complementary mechanisms:

  1. Ovulation inhibition: The combination of desogestrel (as etonogestrel) and ethinyl estradiol suppresses the hypothalamic‑pituitary‑ovarian axis. It reduces the secretion of gonadotrophin‑releasing hormone (GnRH), thereby blunting the luteinising hormone (LH) surge and preventing follicular rupture.
  2. Cervical mucus thickening: Progestogen dominance increases the viscosity of cervical mucus, forming a physical barrier that inhibits sperm penetration and migration.
  3. Endometrial alteration: The endometrium becomes thin, atrophic, and unreceptive to implantation, providing a third layer of protection even if fertilisation were to occur.
TargetEffectTime course
OvaryNo follicular maturation, anovulationWithin first cycle
CervixThick, impenetrable mucusWithin 4 hours of intake
EndometriumReduced glandular development, atrophyOver days‑weeks

🗒️ Physiological insight: The relative contribution of each mechanism varies among individuals, but ovulation inhibition is the primary and most reliable action.

Absorption & Distribution (Pharmacokinetics)

After oral administration, desogestrel and ethinyl estradiol are rapidly absorbed from the gastrointestinal tract. Desogestrel undergoes extensive first‑pass metabolism in the liver to form the active metabolite etonogestrel.

Absorption

Peak serum concentrations of etonogestrel occur 1.5‑2 hours after dosing; ethinyl estradiol peaks at 1.5 hours. Food does not significantly affect absorption.

Distribution

Etonogestrel is 98% protein‑bound (mainly albumin and sex hormone‑binding globulin, SHBG). Ethinyl estradiol also binds to albumin. Ethinyl estradiol increases hepatic synthesis of SHBG, which can increase total etonogestrel binding.

Steady‑state concentrations are achieved after approximately 5‑7 days of daily dosing.

Metabolic Effects & Elimination

Desogestrel is a prodrug: it is hydroxylated in the liver by cytochrome P450 enzymes (CYP2C9 and CYP2C19) to the active metabolite etonogestrel. Etonogestrel is further metabolised to various inactive conjugates.

Ethinyl estradiol is metabolised primarily by CYP3A4, undergoing aromatic hydroxylation and conjugation as glucuronides and sulphates. It also undergoes enterohepatic recirculation, which contributes to its half‑life.

Both metabolites are excreted in urine (~50%) and faeces (~35%) with an elimination half‑life of approximately 36‑38 hours.

⚠️ Metabolic caution: Drugs that induce CYP3A4 (e.g., rifampicin, some anticonvulsants, St John’s wort) can accelerate ethinyl estradiol metabolism and reduce contraceptive efficacy.

Clinical Efficacy in Contraception

When taken correctly (one tablet daily for 21 days followed by a 7‑day break), Marvelon has a Pearl Index of approximately 0.1‑0.9. This means fewer than 1 pregnancy per 100 woman‑years. Typical‑use failure rates are higher (around 2‑3%) due to missed pills or drug interactions.

  • Cycle control: Most women experience regular withdrawal bleeds during the pill‑free interval.
  • Non‑contraceptive benefits: Reduced menstrual pain, lighter bleeding, and lower risk of ovarian and endometrial cancer with long‑term use.
  • Reversibility: Fertility returns rapidly; about 20% of women conceive in the first cycle after stopping, and 80% within one year.

Marvelon FAQs

If started on the first day of your period, Marvelon provides immediate protection. If started on day 2‑5, use additional contraception (e.g., condoms) for the first 7 days.

Weight gain is reported uncommonly (up to 1 in 10). It is usually mild and often due to fluid retention rather than fat accumulation.

If you are less than 12 hours late, take it immediately and continue normally. If more than 12 hours late, follow the PIL instructions: you may need emergency contraception and extra protection for 7 days.

Most antibiotics (except rifampicin/rifabutin) do not affect Marvelon. However, if you experience vomiting or severe diarrhoea while on antibiotics, follow missed‑pill advice.

Current users have a slightly increased relative risk, which returns to baseline within 10 years of stopping. The absolute risk remains small, especially in younger women.

Need Marvelon with Expert Guidance?

If you’re considering Marvelon for contraception, a UK‑registered doctor can assess your suitability and provide a prescription online after a consultation.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Contraception Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co‑founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up‑to‑date.

Medical Doctor

Dr. Feroz is a GMC‑registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co‑founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 17 March 2026

Next Review: 17 September 2026

Published on: 17 March 2026

Last Updated: 17 March 2026